UNICREDIT BANK/CALL/MODERNA/250/0.1/15.01.25 Stock

Warrant

DE000HC4QVE4

Market Closed - BOERSE MUENCHEN 03:42:05 2024-07-05 pm EDT
0.13 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/MODERNA/250/0.1/15.01.25
6 months-68.29%
Current year-55.17%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 0.13 0.00%
24-07-04 0.13 0.00%
24-07-03 0.13 -7.14%
24-07-02 0.14 0.00%
24-07-01 0.14 +7.69%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 03:42 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC4QVE
ISINDE000HC4QVE4
Date issued 2023-03-03
Strike 250 $
Maturity 2025-01-15 (193 Days)
Parity 10 : 1
Emission price 1.77
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.41
Lowest since issue 0.027
Spread 0.02
Spread %13.33%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
118.3 USD
Average target price
145.9 USD
Spread / Average Target
+23.27%
Consensus